Related Experiment Video
Updated: Jun 9, 2026

Protocol to Create Chronic Wounds in Diabetic Mice
Published on: September 25, 2019
[Different expression of chaperone interacting protein in normal, scar and chronic ulcer tissues and its relationship
Xiaobing Fu1, Hui Zhang, Xialian Xu
1Key Research Laboratory of Wound Repair of PLA, 304th Clinical Department, General Hospital of PLA, Beijing, 100037, PR China. fuxb@cgw.net.cn
Objective:
To explore the expression characteristics of chaperone interacting protein (CHIP) in normal, scar and chronic ulcer tissues and its relationship with wound healing.
Methods:
Twenty biopsies including scar tissues (n = 8), chronic ulcer tissues (n = 4) and normal tissues (n = 8) were used in this study. The immunohistochemical staining (power vision two-step histo-staining reagent) was used to explore the amount and expression characteristics of such protein.
Results:
The positive expression of CHIP was observed in fibroblasts, endothelial cells and epidermal cells in dermis and epidermis. It was not seen in inflammatory cells. The expression amount of CHIP in scar tissues, chronic ulcer tissues and normal tissues was 89%, 83% and 17% respectively.
Conclusion:
Although the function of CHIP is not fully understood at present, the fact that this protein is expressed only at the mitogenic cells indicates that it may be involved in mitogenic regulation during wound healing.
Related Concept Videos
Inflammatory Response II: Inflammatory Exudate and Tissue Repair
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the exudate's...
Clinical Applications of Epidermal Stem Cells
Phases of Wound Repair
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
Chronic Inflammation: Introduction
Healing I: Introduction
Healing II: Complications

